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Liver transplantation has become a standard treatment for end-stage liver disease and the number of recipients has grown rapidly in the last few years. Dental care during 
pre-transplant workup is important to reduce potential sources of infection in the drug-
induced immunosuppression phase of liver transplantation. Objectives: The objectives of 
this study were to document the prevalence of oral abnormalities in patients on a liver 
transplant waiting list presenting to an urban dental school clinic, discuss the appropriate 
dental treatment according their systemic conditions and compare their oral manifestations 
with those of healthy individuals. Material and Methods: A pilot study was conducted 
involving 16 end-stage liver disease individuals (study group- SG) attending the Special 
Care Dentistry Center of the University of São Paulo and 16 control individuals (control 
group- CG) with no liver diseases, receiving dental care at the Dental School of the 
University of São Paulo. These individuals were assessed for their dental status (presence 
of oral disease or abnormalities), coagulation status, and dental treatment indications. 
Results: The patients from SG exhibited a greater incidence of oral manifestations compared 
with CG (p=0.0327) and were diagnosed with at least one oral disease or condition that 
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were found in 93.75% of the patients. However, no bleeding complications occurred after 
dental treatment. Conclusions: The patients with chronic liver diseases evaluated in this 
study exhibited a higher incidence of oral manifestations compared with the control group 
and had at least one oral disease or abnormality which required dental treatment prior 
to liver transplantation. Careful oral examination and evaluation of the patient, including 
laboratory tests, will ensure correct oral preparation and control of oral disease prior to 
liver transplantation.
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INTRODUCTION
There several liver conditions that cause chronic 
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common causes of end-stage liver disease are 
chronic viral hepatitis B and C, alcohol-related liver 
disease, autoimmune hepatitis, primary sclerosing 
cholangitis, primary biliary cirrhosis, steatohepatitis, 
liver disorders inherited or present at birth, and 
drug-induced liver damage2.
In Brazil, since 2006, donor liver allocation has 
been based on the model for end-stage liver disease 
(MELD) scoring system. At present, the MELD has 
been validated on a broad series of patients with 
liver diseases of various etiologies and severity1. The 
lab values used in the MELD calculation are serum 
bilirrubin, International Normalization Ratio (INR) 
and serum creatinine1 (Figure 1).
The relationship between the introduction of the 
MELD allocation system in Brazil and a reduction of 
donor organ waiting list mortality is controversial. 
However, the number of recipients of liver transplants 
has grown dramatically in the last few years and is 
likely to continue to do so in the future1.
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The improved survival rates and transplant 
outcomes is predicated upon proper screening and 
evaluation, as well as breakthroughs in surgical 
techniques and immunosuppressive therapies. 
Despite these breakthroughs, infection continues to 
be a leading cause in graft loss or death of transplant 
recipients. Although evaluation for chronic systemic 
infections in transplant recipients is standard, 
this cannot be said of pre-transplantation dental 
evaluation2,9.
A survey of United States organ transplant 
centers, conducted between 2003 and 2004, found 
that among the 294 respondents, 28 (9%) of organ 
transplant centers reported one or more incidents 
of sepsis of dental origin in transplant recipients4. 
In this same survey, 34 (11%) transplant centers 
reported experiencing one or more episodes of a 
dental infection prior to transplantation that needed 
cancellation or postponement of the surgery.
A study performed by the Starzl Transplant 
Institute involving 300 candidates for liver 
transplantation conducted between January 2004 
and March 2005, reported that oral health attributes 
(i.e., gingivitis, dental plaque, dental caries, 
periodontal disease, edentulism, and xerostomia) 
were similar to those seen in the general population. 
Candidates for liver transplantation who have not 
had a dental evaluation for more than 1 year were 
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oral health, untreated dental conditions or habits 
(e.g., smoking) that were potential precursors and 
risk factors for dental disease3.
Providing oral health care pre- and post-liver 
transplantation is essential for a better prognosis 
and quality of life of transplant recipients. The main 
concern before the transplantation is to eliminate 
oral foci of infection, such as those of periapical 
and periodontal origin. During the post-transplant 
period, the dental professional must be aware of the 
increased susceptibility to infection in the patient, and 
the risk for organ rejection, both of which emphasize 
the importance of vigilant oral health maintenance. 
Patients are severely immunocompromised and must 
be well-educated and treated for the rest of their 
post-transplant lives9.
The objectives of this study were to document 
the prevalence of oral disease and abnormalities 
in patients on a liver transplant waiting list 
presenting to an urban dental school clinic, discuss 
the appropriated dental treatment, according 
their systemic conditions and compare the oral 
manifestations with those of healthy individuals.
PATIENTS AND METHODS
This study was approved by the Research 
Ethics Committee of the School of Dentistry of 
the University of São Paulo. All patients signed an 
informed consent form.
A pilot study was conducted involving 16 end-
stage liver disease individuals (study group - SG) 
attending the Special Care Dentistry Center of the 
University of São Paulo and 16 control individuals 
(control group - CG) with no liver diseases, who 
were receiving dental care at the Dental School of 
the University of São Paulo. SG was formed by all 
patients with end-stage liver disease that had been 
referred to the Special Care Dentistry Center for 
routine dental treatment.
Medical history review and physical examination, 
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for this study, were compiled in a special form for 
all the patients.
All patients were questioned about variables 
such as demographics and history of liver disease. 
Coagulation studies [i.e., prothrombin time (PT)/
International Normalization Ratio (INR), activated 
partial thromboplastin time (aPTT), and platelet 
count] were also performed on all patients.
The dental status of each patient was evaluated 
at the initial visit by two trained oral medicine 
dentists. The patient evaluation consisted of a 
clinical examination of the hard and soft oral tissues 
and a radiographic examination which consisted 
in panoramic and periapical radiography. All 
abnormalities detected in each patient were recorded 
using a special form designed for this study.
Based upon each patient’s dental treatment 
indications and needs, a dental treatment plan 
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recommendations for each patient were presented.
RESULTS
Among 16 individuals from SG, 13 were male and 
3 were female, ranging in age from 37 to 68 (median 
age of 51 years). Of the 16 individuals from CG, 13 
were male and 3 were female, ranging in age from 
34 to 70 (median age to 50 years).
The patients with end-stage liver disease 
presented hepatitis C and alcohol related liver 
disease (5/16; 31.25%), hepatitis C (5/16; 31.25%), 
alcohol-related liver disease (3/16; 18.75%), 
hepatitis and alcohol related liver disease B (2/16; 
Laboratory tests Value labs
Bilirrubin mg/dl
Creatinine mg/dl
INR 
3.8[Ln serum bilirubin (mg/dL)] + 11.2[Ln 
INR] + 9.6[Ln serum creatinine (mg/dL)] 
+ 6.4
level
Figure 1- Model for end-stage liver disease (MELD)
calculation 
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12.5%) and Wilson disease (1/16; 6.5%) (Figure 2).
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increased risk of bleeding, were found in 15 patients 
from SG (15/16; 93.75%). The most common 
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96x109/L) found in 11 patients (11/16; 68.75%), 
followed by prolonged PT (10 to 52 s) in 13 patients 
(13/16; 81.25%), prolonged aPTT (52 to 46.9 s) in 5 
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in 7 patients (7/16; 43.75%).
Data collected from oral and radiographic 
examinations showed that all patients from SG 
(100%) were diagnosed with least one oral disease 
or condition that would require dental treatment prior 
to liver transplantation. Caries was diagnosed in 13 
patients (13/16; 81.25%); periodontal disease in 11 
patients (11/16; 68.75%); petechiae in 3 patients 
(3/16; 18.75%); oral candidiasis in 2 patients (2/16; 
12.5%); and gingival overgrowth, ulceration caused 
by cytomegalovirus (CMV), xerostomia and angular 
cheilitis were diagnosed 1 patient (1/16; 6.25%). 
The patients from CG presented caries (7/16; 
43.75%), periodontal disease (10/16; 62.5%) and 
oral candidiasis (1/16; 6.25%).
The diagnosis of ulceration caused by CMV was 
detected with PCR real time. Gingival overgrowth 
was associated with severe periodontal disease and 
poor oral hygiene. The petechiae were associated in 
the three cases with thrombocytopenia.
The individuals from SG exhibited a higher 
incidence of oral diseases compared with those 
from CG (p=0.0327). Figure 3 summarizes the oral 
Figure 2- Characteristics of the liver transplant candidates 
Patients Age Subject Liver diseases diagnoses
1 44 Male Hepatitis type B and alcohol-related liver disease
2 52 Male Hepatitis type C
3 46 Male Hepatitis type C and alcohol-related liver disease
4 37 Male Hepatitis type C and alcohol-related liver disease
5 47 Male Hepatitis type C
6 43 Male Hepatitis type C and alcohol-related liver disease
7 54 Male Alcohol-related liver disease
8 57 Male Hepatitis type C and alcohol-related liver disease
9 43 Male Wilson disease
10 60 Male Hepatitis type B and alcohol-related liver disease
11 44 Female Hepatitis type C
12 60 Male Hepatitis type C
13 68 Female Hepatitis type C
14 43 Male Alcohol-related liver disease
15 55 Male Alcohol-related liver disease
16 61 Female Hepatitis type C and alcohol-related liver disease
Figure 3- Oral manifestations of study group and control group patients
CMV=cytomegalovirus
SILVA SANTOS PS, FERNANDES KS, GALLOTTINI MHC
2012;20(2):241-5
J Appl Oral Sci. 244
conditions found in all individuals enrolled in this 
study. Table 1 shows the oral manifestations from 
SG and abnormalities coagulation.
After the initial exam and diagnosis of oral 
diseases, indicated dental treatment procedures 
were performed on all patients (SG and CG) by 
the same dentists and included 20 restorations, 21 
periodontal scaling and root planning procedures, 6 
extractions, 1 incisional biopsy, 3 brush (exfoliative) 
cytology exams, 2 prosthetic rehabilitations (1 
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endodontic treatments.
Although the majority of patients showed 
abnormal coagulation values, none of them exhibited 
critical values that would represent a contraindication 
for invasive dental treatment. For this reason, 
the dental treatments were conducted in our 
outpatient clinic. Procedures that involve bleeding, 
such as dental extraction, biopsy and periodontal 
treatment, were conducted using hemostatic local 
measurements, such as tranexamic acid paste and 
absorbable gelatin sterile sponge, as recommended 
by Ramstrom, et al.8 (1993) and Rada7 (2006).
DISCUSSION
Transplant centers are very specialized facilities 
that are usually located at university teaching 
hospitals or large medical centers. They require a 
large staff of surgeons and other professionals to 
evaluate and select patients, and perform surgery 
and follow-up care. However, even though patients 
are on waiting lists for matching donor livers for 
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this is not a major priority on the protocols of some 
transplant centers in our city.
The individuals from SG exhibited a higher 
incidence of oral manifestations compared with CG 
(p=0.0327) and all of them were diagnosed with 
at least one oral abnormality that required dental 
treatment prior liver transplantation in order to 
avoid potential complications due to infection after 
transplantation secondary to drug-induced, anti-
organ rejection immunosuppression.
The major concern for dental management 
of patients with end-stage liver disease is the 
occurrence of bleeding disorders. Routine dental 
procedures such as dental prophylaxis, tooth 
extractions, minor periodontal surgeries, and even 
administration of local anesthetic for restorations can 
result in serious complications if the dentist is not 
Patients Oral manifestations Labs values
Platelet
(56 to 96x109/L)
aPTT
(46.9 to 52 s)
PT
(10 to 52 s)
INR
(>1.3)
1 PD, GO, caries 70 49 8 1.1
2 PD, caries 62 39.25 15.15 1.26
3 PD 99 42 10 0.72
4 PD, caries, OC 56 51 7 1.6
5 DP, caries 54 47 15 1.15
6 caries 42.6 45.7 14.5 1.82
7 DP, caries 50 44.6 24.3 1.66
8 PTC, OC, AC 96 46.3 25.7 1.54
9 PD, caries, PTC, CMV, 
xerostomia
41 41.5 19.6 1.52
10 PD, caries, PTC 64.5 46.9 18 2.67
11 caries 257 37 13 1.14
12 PD, caries 101 36 14 1
13 PD, caries 336 25.2 14.9 0.9
14 caries 290 29.5 12.9 1.12
15 caries 38 31.8 17.3 1.31
16 PD, caries 18 35.2 16.7 1.29
Table 1- Oral manifestations and coagulation abnormalities
Legend: PD=periodontal disease; GO=gingival overgrowth; OC=oral candidiasis; PTC=petechiae; AC=angular cheilitis; 
CMV=ulceration caused by cytomegalovirus; aPTT=activated partial thromboplastin time; PT=prothrombin time; 
INR=international normalization ratio
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aware of potential risk for impaired hemostasis and 
increased bleeding in these patients. It is generally 
accepted that minimally invasive procedures such 
as simple restorations, supra-gingival prophylaxis, 
and prosthodontic procedures do not usually involve 
a considerable risk of bleeding when compared 
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procedures with a moderate level of invasiveness 
such as subgingival scaling (especially in the 
presence of more severe periodontal disease) and 
extensive (e.g., subgingival) restorations.
In patients with mild to moderate hemostatic 
impairment, (i.e., INR not greater than 3.5, or 
a platelet count not less than 50x109 L) careful 
surgical technique, including an attempt at obtaining 
primary wound closure and use of local hemostatic 
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hemostatic materials improves clot formation and 
stability. However, these materials also carry a 
risk of infection and may delay healing and should 
therefore be avoided in immunosuppressed patients. 
Topical thrombin is an effective agent when applied 
directly on the bleeding wound as it converts 
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of factor replacement needed when used along 
with antifibrinolytic agents. Oxidized cellulose 
tranexamic acid rinses, astringents (e.g., aluminum 
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absorbable gelatin sponges, and amino-caproic acid 
(EACA) to prevent clot lysis, have all been suggested 
as aids to hemostasis in this setting5,6,10.
Patients with liver failure from any cause are 
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oral bleeding. A relatively small elevation of the PT 
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greater than 50%) liver damage.
There are various systemic methods that can 
be used to help compensate for the coagulopathies 
seen in these patients and decrease the risk of 
prolonged bleeding from invasive dental procedures. 
Vitamin K (at doses of 10 mg IM) corrects 
hypoprothrombinemia from malnutrition and biliary 
obstruction, but not when due to intrinsic liver 
disease. Fresh frozen plasma will lower the PT, and 
platelet transfusion addresses both quantitative 
and qualitative platelet defects. In the case of 
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an invasive procedure may need to be adjusted 
accordingly, and the patient should be observed 
postoperatively in the surgery for a longer time 
period than usual5,6.
Care should be exercised with the use of narcotic 
analgesics (e.g., morphine) and sedatives (e.g., 
diazepam), as their duration of action may be 
prolonged in patients with decompensated liver 
disease. As with chronic renal failure, reduced doses 
should be used for drugs that are metabolized by 
the liver. In particular, avoid the use of paracetamol 
in the presence of liver failure and alcoholism, 
although doses of up to 4 g/day for up to 2 weeks 
are allowable. Patients should be strongly advised 
not to take alcohol during the period when they are 
using acetaminophen.
Careful oral examination and evaluation of the 
patient, including laboratory tests, will ensure 
correct oral preparation and control of oral disease 
prior to liver transplantation. Patients with chronic 
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treatment and therefore general dentists should 
be aware of the unique concerns involving their 
assessment, education, treatment and maintenance 
of oral health.
CONCLUSION
The patients with chronic liver diseases evaluated 
in this study exhibited a higher incidence of 
oral manifestations compared with the healthy 
control group and had at least one oral disease or 
abnormality that required dental treatment prior to 
liver transplantation.
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